1. Home
  2. NMTC

as of 12-10-2025 1:41pm EST

$0.61
$0.02
-2.54%
Stocks Health Care Medical/Dental Instruments Nasdaq

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Chart Type:
Time Range:
Founded: 2009 Country:
United States
United States
Employees: N/A City: EDEN PRAIRIE
Market Cap: 31.5M IPO Year: N/A
Target Price: $2.23 AVG Volume (30 days): 130.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.15 EPS Growth: N/A
52 Week Low/High: $0.40 - $1.39 Next Earning Date: 12-15-2025
Revenue: $6,629,051 Revenue Growth: 69.00%
Revenue Growth (this year): 162.84% Revenue Growth (next year): 26.51%

AI-Powered NMTC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 19 hours ago

AI Recommendation

hold
Model Accuracy: 71.23%
71.23%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest NeuroOne Medical Technologies Corporation News

NMTC Breaking Stock News: Dive into NMTC Ticker-Specific Updates for Smart Investing

All NMTC News

Share on Social Networks: